Read this manager's filing book
Disclosed positions
Morgan Creek Capital Management, LLC: source evidence dated 2026-08-15T03:59:59.999Z.
- Issuer
- FIGURE TECHNOLOGY SOLUTIO
- Ticker
- FIGR
- Class
- COM CL A
- Reported value
- $136,423,555
- Reported amount
- 4,442,317
- Unit
- SH
- Option
- None
The displayed owner or issuer and source fields identify the receipt to verify; keep reporting and availability dates separate.
What was reported for this quarter?
13F positions are dated quarter-end holdings, with later publication and possible amendments. Read report period and availability before calling them current.
SEC 13F-HR: 0001398344-26-014541Open the effective filing receipt and inspect shares, value and any put/call classification separately.
Browse institutional filings
Open the effective filing receipt and inspect shares, value and any put/call classification separately.
Browse institutional filingsKeep reporting dates and units beside the answer, and inspect its original citations.
Disclosed positions
See the complete disclosed positions
| FIGURE TECHNOLOGY SOLUTIO | FIGR | COM CL A | $136,423,555 | 4,442,317 | SH | None |
| UBER TECHNOLOGIES INC | UBER | COM | $3,248,859 | 45,023 | SH | None |
| GEMINI SPACE STA INC | GEMI | CL A COM | $2,395,096 | 562,229 | SH | None |
| LYFT INC | LYFT | CL A COM | $1,427,631 | 97,716 | SH | None |
| FULL TRUCK ALLIANCE CO LTD | YMM | SPONSORED ADS | $1,413,732 | 174,105 | SH | None |
| IHS HOLDING LIMITED | IHS | ORD SHS | $1,276,896 | 154,963 | SH | None |
| PLAINS ALL AMERN PIPELINE L | PAA | UNIT LTD PARTN | $392,711 | 17,642 | SH | None |
| BIOHAVEN LTD | BHVN | COM | $270,712 | 18,193 | SH | None |
| ACADIA PHARMACEUTICALS INC | ACAD | COM | $237,694 | 9,395 | SH | None |
| VERADERMICS INC | MANE | COMMON STOCK | $236,660 | 1,925 | SH | None |
| ARRIVENT BIOPHARMA INC | AVBP | COM | $229,284 | 6,600 | SH | None |
| PTC THERAPEUTICS INC | PTCT | COM | $224,481 | 2,752 | SH | None |
| TAIWAN SEMICONDUCTOR MANUFAC | TSM | SPONSORED ADS | $216,339 | 453 | SH | None |
| REGENERON PHARMACEUTICALS | REGN | COM | $207,015 | 332 | SH | None |
| INSMED INC | INSM | COM PAR $.01 | $205,670 | 1,929 | SH | None |
No matching rows. Clear the filter to see all records.
Largest 50 positions by reported value; the filing may contain more positions.
How amendments affect these holdings
This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 0 positions lack a resolved ticker and 0 positions are put or call entries.
A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.
Quarter end and public filing date
Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.